Global Peptide Receptor Radionuclide Therapy (PRRT) Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Peptide Receptor Radionuclide Therapy (PRRT) market size was valued at US$ 1020.3 million in 2023. With growing demand in downstream market, the Peptide Receptor Radionuclide Therapy (PRRT) is forecast to a readjusted size of US$ 3265.9 million by 2030 with a CAGR of 18.1% during review period.
The research report highlights the growth potential of the global Peptide Receptor Radionuclide Therapy (PRRT) market. Peptide Receptor Radionuclide Therapy (PRRT) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peptide Receptor Radionuclide Therapy (PRRT). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peptide Receptor Radionuclide Therapy (PRRT) market.
Peptide receptor radionuclide therapy (PRRT) is a type of molecular therapy, also known as radioisotope therapy that is used for treating neuroendocrine tumors.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Peptide Receptor Radionuclide Therapy (PRRT) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peptide Receptor Radionuclide Therapy (PRRT) market. It may include historical data, market segmentation by Type (e.g., Gastroenteropancreatic Neuroendocrine Tumor, Foregut Neuroendocrine Tumor), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peptide Receptor Radionuclide Therapy (PRRT) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peptide Receptor Radionuclide Therapy (PRRT) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peptide Receptor Radionuclide Therapy (PRRT) industry. This include advancements in Peptide Receptor Radionuclide Therapy (PRRT) technology, Peptide Receptor Radionuclide Therapy (PRRT) new entrants, Peptide Receptor Radionuclide Therapy (PRRT) new investment, and other innovations that are shaping the future of Peptide Receptor Radionuclide Therapy (PRRT).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peptide Receptor Radionuclide Therapy (PRRT) market. It includes factors influencing customer ' purchasing decisions, preferences for Peptide Receptor Radionuclide Therapy (PRRT) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peptide Receptor Radionuclide Therapy (PRRT) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peptide Receptor Radionuclide Therapy (PRRT) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peptide Receptor Radionuclide Therapy (PRRT) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peptide Receptor Radionuclide Therapy (PRRT) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peptide Receptor Radionuclide Therapy (PRRT) market.
Market Segmentation:
Peptide Receptor Radionuclide Therapy (PRRT) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Peptide Receptor Radionuclide Therapy (PRRT) market size was valued at US$ 1020.3 million in 2023. With growing demand in downstream market, the Peptide Receptor Radionuclide Therapy (PRRT) is forecast to a readjusted size of US$ 3265.9 million by 2030 with a CAGR of 18.1% during review period.
The research report highlights the growth potential of the global Peptide Receptor Radionuclide Therapy (PRRT) market. Peptide Receptor Radionuclide Therapy (PRRT) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peptide Receptor Radionuclide Therapy (PRRT). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peptide Receptor Radionuclide Therapy (PRRT) market.
Peptide receptor radionuclide therapy (PRRT) is a type of molecular therapy, also known as radioisotope therapy that is used for treating neuroendocrine tumors.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Peptide Receptor Radionuclide Therapy (PRRT) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peptide Receptor Radionuclide Therapy (PRRT) market. It may include historical data, market segmentation by Type (e.g., Gastroenteropancreatic Neuroendocrine Tumor, Foregut Neuroendocrine Tumor), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peptide Receptor Radionuclide Therapy (PRRT) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peptide Receptor Radionuclide Therapy (PRRT) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peptide Receptor Radionuclide Therapy (PRRT) industry. This include advancements in Peptide Receptor Radionuclide Therapy (PRRT) technology, Peptide Receptor Radionuclide Therapy (PRRT) new entrants, Peptide Receptor Radionuclide Therapy (PRRT) new investment, and other innovations that are shaping the future of Peptide Receptor Radionuclide Therapy (PRRT).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peptide Receptor Radionuclide Therapy (PRRT) market. It includes factors influencing customer ' purchasing decisions, preferences for Peptide Receptor Radionuclide Therapy (PRRT) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peptide Receptor Radionuclide Therapy (PRRT) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peptide Receptor Radionuclide Therapy (PRRT) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peptide Receptor Radionuclide Therapy (PRRT) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peptide Receptor Radionuclide Therapy (PRRT) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peptide Receptor Radionuclide Therapy (PRRT) market.
Market Segmentation:
Peptide Receptor Radionuclide Therapy (PRRT) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Gastroenteropancreatic Neuroendocrine Tumor
- Foregut Neuroendocrine Tumor
- Midgut Neuroendocrine Tumor
- Hindgut Neuroendocrine Tumor
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Novartis
- Lantheus
- Aurobindo Pharma
- Mundipharma
- Curium Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2019-2030
2.1.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Peptide Receptor Radionuclide Therapy (PRRT) Segment by Type
2.2.1 Gastroenteropancreatic Neuroendocrine Tumor
2.2.2 Foregut Neuroendocrine Tumor
2.2.3 Midgut Neuroendocrine Tumor
2.2.4 Hindgut Neuroendocrine Tumor
2.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
2.3.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
2.4 Peptide Receptor Radionuclide Therapy (PRRT) Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
2.5.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
3 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) MARKET SIZE BY PLAYER
3.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Players
3.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Players (2019-2024)
3.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Players (2019-2024)
3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) BY REGIONS
4.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions (2019-2024)
4.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2019-2024)
4.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2019-2024)
4.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2019-2024)
4.5 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2019-2024)
5.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024)
5.3 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2019-2024)
6.2 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024)
6.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) by Country (2019-2024)
7.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024)
7.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) by Region (2019-2024)
8.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024)
8.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) MARKET FORECAST
10.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Regions (2025-2030)
10.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Regions (2025-2030)
10.1.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.1.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.1.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.1.5 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Country (2025-2030)
10.2.1 United States Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.2.2 Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.2.3 Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.2.4 Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Region (2025-2030)
10.3.1 China Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.2 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.3 Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.4 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.5 India Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.6 Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Country (2025-2030)
10.4.1 Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4.2 France Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4.3 UK Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4.4 Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4.5 Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Region (2025-2030)
10.5.1 Egypt Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5.2 South Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5.3 Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5.4 Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5.5 GCC Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.6 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Type (2025-2030)
10.7 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.1.3 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.2.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Lantheus
11.3.1 Lantheus Company Information
11.3.2 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.3.3 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Lantheus Main Business Overview
11.3.5 Lantheus Latest Developments
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Company Information
11.4.2 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.4.3 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Aurobindo Pharma Main Business Overview
11.4.5 Aurobindo Pharma Latest Developments
11.5 Mundipharma
11.5.1 Mundipharma Company Information
11.5.2 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.5.3 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Mundipharma Main Business Overview
11.5.5 Mundipharma Latest Developments
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Information
11.6.2 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.6.3 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Curium Pharmaceuticals Main Business Overview
11.6.5 Curium Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2019-2030
2.1.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Peptide Receptor Radionuclide Therapy (PRRT) Segment by Type
2.2.1 Gastroenteropancreatic Neuroendocrine Tumor
2.2.2 Foregut Neuroendocrine Tumor
2.2.3 Midgut Neuroendocrine Tumor
2.2.4 Hindgut Neuroendocrine Tumor
2.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
2.3.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
2.4 Peptide Receptor Radionuclide Therapy (PRRT) Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
2.5.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
3 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) MARKET SIZE BY PLAYER
3.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Players
3.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Players (2019-2024)
3.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Players (2019-2024)
3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) BY REGIONS
4.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions (2019-2024)
4.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2019-2024)
4.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2019-2024)
4.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2019-2024)
4.5 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2019-2024)
5.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024)
5.3 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2019-2024)
6.2 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024)
6.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) by Country (2019-2024)
7.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024)
7.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) by Region (2019-2024)
8.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024)
8.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) MARKET FORECAST
10.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Regions (2025-2030)
10.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Regions (2025-2030)
10.1.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.1.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.1.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.1.5 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Country (2025-2030)
10.2.1 United States Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.2.2 Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.2.3 Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.2.4 Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Region (2025-2030)
10.3.1 China Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.2 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.3 Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.4 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.5 India Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.6 Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Country (2025-2030)
10.4.1 Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4.2 France Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4.3 UK Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4.4 Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4.5 Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Region (2025-2030)
10.5.1 Egypt Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5.2 South Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5.3 Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5.4 Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5.5 GCC Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.6 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Type (2025-2030)
10.7 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.1.3 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.2.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Lantheus
11.3.1 Lantheus Company Information
11.3.2 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.3.3 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Lantheus Main Business Overview
11.3.5 Lantheus Latest Developments
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Company Information
11.4.2 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.4.3 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Aurobindo Pharma Main Business Overview
11.4.5 Aurobindo Pharma Latest Developments
11.5 Mundipharma
11.5.1 Mundipharma Company Information
11.5.2 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.5.3 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Mundipharma Main Business Overview
11.5.5 Mundipharma Latest Developments
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Information
11.6.2 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.6.3 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Curium Pharmaceuticals Main Business Overview
11.6.5 Curium Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Gastroenteropancreatic Neuroendocrine Tumor
Table 3. Major Players of Foregut Neuroendocrine Tumor
Table 4. Major Players of Midgut Neuroendocrine Tumor
Table 5. Major Players of Hindgut Neuroendocrine Tumor
Table 6. Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Table 9. Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Table 12. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Player (2019-2024)
Table 14. Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Products Offered
Table 15. Peptide Receptor Radionuclide Therapy (PRRT) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Regions (2019-2024)
Table 20. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Country (2019-2024)
Table 24. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Table 26. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Table 28. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region (2019-2024)
Table 30. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Table 32. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Table 34. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Country (2019-2024)
Table 36. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Table 38. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Peptide Receptor Radionuclide Therapy (PRRT)
Table 47. Key Market Challenges & Risks of Peptide Receptor Radionuclide Therapy (PRRT)
Table 48. Key Industry Trends of Peptide Receptor Radionuclide Therapy (PRRT)
Table 49. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Bayer Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 54. Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 55. Bayer Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Bayer Main Business
Table 57. Bayer Latest Developments
Table 58. Novartis Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 59. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Novartis Latest Developments
Table 63. Lantheus Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 64. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 65. Lantheus Main Business
Table 66. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Lantheus Latest Developments
Table 68. Aurobindo Pharma Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 69. Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 70. Aurobindo Pharma Main Business
Table 71. Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Aurobindo Pharma Latest Developments
Table 73. Mundipharma Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 74. Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 75. Mundipharma Main Business
Table 76. Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Mundipharma Latest Developments
Table 78. Curium Pharmaceuticals Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 79. Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 80. Curium Pharmaceuticals Main Business
Table 81. Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Curium Pharmaceuticals Latest Developments
Table 1. Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Gastroenteropancreatic Neuroendocrine Tumor
Table 3. Major Players of Foregut Neuroendocrine Tumor
Table 4. Major Players of Midgut Neuroendocrine Tumor
Table 5. Major Players of Hindgut Neuroendocrine Tumor
Table 6. Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Table 9. Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Table 12. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Player (2019-2024)
Table 14. Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Products Offered
Table 15. Peptide Receptor Radionuclide Therapy (PRRT) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Regions (2019-2024)
Table 20. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Country (2019-2024)
Table 24. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Table 26. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Table 28. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region (2019-2024)
Table 30. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Table 32. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Table 34. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Country (2019-2024)
Table 36. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Table 38. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Peptide Receptor Radionuclide Therapy (PRRT)
Table 47. Key Market Challenges & Risks of Peptide Receptor Radionuclide Therapy (PRRT)
Table 48. Key Industry Trends of Peptide Receptor Radionuclide Therapy (PRRT)
Table 49. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Bayer Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 54. Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 55. Bayer Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Bayer Main Business
Table 57. Bayer Latest Developments
Table 58. Novartis Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 59. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Novartis Latest Developments
Table 63. Lantheus Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 64. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 65. Lantheus Main Business
Table 66. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Lantheus Latest Developments
Table 68. Aurobindo Pharma Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 69. Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 70. Aurobindo Pharma Main Business
Table 71. Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Aurobindo Pharma Latest Developments
Table 73. Mundipharma Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 74. Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 75. Mundipharma Main Business
Table 76. Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Mundipharma Latest Developments
Table 78. Curium Pharmaceuticals Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 79. Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 80. Curium Pharmaceuticals Main Business
Table 81. Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Curium Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Peptide Receptor Radionuclide Therapy (PRRT) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Peptide Receptor Radionuclide Therapy (PRRT) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Country/Region (2023)
Figure 8. Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type in 2023
Figure 10. Peptide Receptor Radionuclide Therapy (PRRT) in Hospital Pharmacies
Figure 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Hospital Pharmacies (2019-2024) & ($ Millions)
Figure 12. Peptide Receptor Radionuclide Therapy (PRRT) in Retail Pharmacies
Figure 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Retail Pharmacies (2019-2024) & ($ Millions)
Figure 14. Peptide Receptor Radionuclide Therapy (PRRT) in Online Pharmacies
Figure 15. Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Online Pharmacies (2019-2024) & ($ Millions)
Figure 16. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application in 2023
Figure 17. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Player in 2023
Figure 18. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Peptide Receptor Radionuclide Therapy (PRRT) Value Market Share by Country in 2023
Figure 24. United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region in 2023
Figure 29. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type in 2023
Figure 30. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application in 2023
Figure 31. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Country in 2023
Figure 38. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 57. United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 61. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 65. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 68. France Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 69. UK Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 78. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Peptide Receptor Radionuclide Therapy (PRRT) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Peptide Receptor Radionuclide Therapy (PRRT) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Country/Region (2023)
Figure 8. Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type in 2023
Figure 10. Peptide Receptor Radionuclide Therapy (PRRT) in Hospital Pharmacies
Figure 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Hospital Pharmacies (2019-2024) & ($ Millions)
Figure 12. Peptide Receptor Radionuclide Therapy (PRRT) in Retail Pharmacies
Figure 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Retail Pharmacies (2019-2024) & ($ Millions)
Figure 14. Peptide Receptor Radionuclide Therapy (PRRT) in Online Pharmacies
Figure 15. Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Online Pharmacies (2019-2024) & ($ Millions)
Figure 16. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application in 2023
Figure 17. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Player in 2023
Figure 18. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Peptide Receptor Radionuclide Therapy (PRRT) Value Market Share by Country in 2023
Figure 24. United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region in 2023
Figure 29. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type in 2023
Figure 30. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application in 2023
Figure 31. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Country in 2023
Figure 38. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 57. United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 61. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 65. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 68. France Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 69. UK Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2025-2030 ($ Millions)
Figure 78. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share Forecast by Application (2025-2030)
